Pentamidine Isethionate Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-03-23 · last update 2026-03-23
Manufacturers: XGen Pharmaceuticals DJB, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2) | XGen Pharmaceuticals DJB, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 03/23/2026 Updated 03/23/2026 Discontinued 03/23/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)